Skip to main content

Table 3 2-year development of decompensated clinical stage in previously compensated cirrhotic patients

From: Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study

Compensated patients

2-year development of first AD event

Univariate Fine-Gray regression

Multivariate Fine-Gray regression

sHR

CI (95%)

p value

sHR

CI (95%)

p value

Age (≥ 50)

1.268

0.461–3.485

0.650

   

Sex (female)

0.543

0.225–1.315

0.180

   

Alcoholic etiology

1.968

0.823–4.706

0.130

   

MELD (5-point increase)

2.592

1.255–5.336

0.010

2.738

1.134–6.607

0.025

Child–Pugh Ba

1.394

0.158–12.260

0.760

   

Presence of comorbidity

2.421

0.965–6.076

0.060

1.157

0.454–2.949

0.760

Presence of HCC

2.862

1.091–7.509

0.033

3.712

1.386–9.946

0.009

CRP (≥ 10)

3.211

1.156–8.924

0.025

2.821

0.842–9.453

0.093

Anemia

4.113

1.731–9.772

0.001

3.193

1.259–8.101

0.015

Low Ferritin

2.782

1.156–6.696

0.022

3.762

1.616–8.760

0.002

  1. Values in bold indicate statistically significant tests
  2. MELD model for end stage liver disease, HCC hepatocellular carcinoma, CRP C-reactive protein, sHR sub-distribution hazard ratio, CI confidence interval
  3. aThere was no Child-C stage patient in compensated group